Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
LNR - As of  05/09/24, 06:39:57 AM:   19 Insider Transactions.

Sector: Unknown    Industry: Unknown
Prev Close:$0.00  Avg Vol(3m): 0  P/E: 0.00  EPS: 0.00

Email this page to a friend.    Insider Transactions for LNR

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
B 2006-02-09 00:00:00.0 LNR PROPERTY CORP LNR BARCLAYS PLC 0.0% view
B 2005-02-16 00:00:00.0 LNR PROPERTY CORP LNR THIRD AVENUE MANAGEMENT LLC 16.18% view
S 2005-02-14 00:00:00.0 LNR PROPERTY CORP LNR HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 9.1% view
B 2005-02-14 00:00:00.0 CytomX Therapeutics CTMX BIOTECHNOLOGY VALUE FUND L P 10.0% view
B 2020-03-06 17:29:37.0 CytomX Therapeutics CTMX BIOTECHNOLOGY VALUE FUND L P 7.0% view
S 2020-02-14 16:18:41.0 CytomX Therapeutics CTMX PRICE T ROWE ASSOCIATES INC 1.5% view
B 2020-02-11 16:40:08.0 CytomX Therapeutics CTMX BlackRock Inc 8.8% view
S 2020-01-27 14:03:24.0 CytomX Therapeutics CTMX WELLINGTON MANAGEMENT GROUP LLP 4.741% view
S 2019-02-14 13:51:07.0 CytomX Therapeutics CTMX PRICE T ROWE ASSOCIATES INC 0.5% view
B 2019-02-13 11:50:36.0 CytomX Therapeutics CTMX FMR LLC 5.95% view
S 2019-02-04 10:07:41.0 CytomX Therapeutics CTMX BlackRock Inc 2.9% view
S 2018-02-13 17:09:06.0 CytomX Therapeutics CTMX PFIZER INC 9.0% view
B 2018-02-13 09:36:09.0 CytomX Therapeutics CTMX FMR LLC 15.0% view
S 2017-12-18 14:32:02.0 CytomX Therapeutics CTMX PERCEPTIVE ADVISORS LLC 0.0% view
B 2017-06-29 17:58:08.0 CytomX Therapeutics CTMX BIOTECHNOLOGY VALUE FUND L P 15.0% view
S 2017-02-13 16:15:04.0 CytomX Therapeutics CTMX THIRD ROCK VENTURES LP 8.9% view
B 2016-02-12 09:06:46.0 CytomX Therapeutics CTMX FMR LLC 14.999% view
B 2016-02-10 16:20:36.0 CytomX Therapeutics CTMX THIRD ROCK VENTURES LP 24.1% view
B 2015-10-21 16:58:39.0 CytomX Therapeutics CTMX PFIZER INC n/a view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.